| case report | Q2782326 |
| scholarly article | Q13442814 |
| P2093 | author name string | H P Wu | |
| C T Peng | |||
| K H Wu | |||
| Y H Chao | |||
| T Weng | |||
| P2860 | cites work | Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia | Q27025242 |
| Dasatinib plus chemotherapy to achieve full donor chimerism and complete molecular remission in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia. | Q50936640 | ||
| Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) | Q58414406 | ||
| Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction | Q58455818 | ||
| Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation | Q67895220 | ||
| Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL) | Q73014178 | ||
| Association study of cyclooxygenase 2 single nucleotide polymorphisms and childhood acute lymphoblastic leukemia in Taiwan | Q85190033 | ||
| Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias | Q28246193 | ||
| Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium | Q34743481 | ||
| Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031. | Q34810036 | ||
| Dasatinib: in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. | Q37063600 | ||
| Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive acute lymphoblastic anemia | Q37967302 | ||
| The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides | Q38052233 | ||
| Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood | Q42769654 | ||
| Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia | Q43617176 | ||
| Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: enhance hematopoiesis after cord blood transplantation | Q43942762 | ||
| Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation | Q44442200 | ||
| Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia. | Q46128720 | ||
| Human Application of Ex-Vivo Expanded Umbilical Cord-Derived Mesenchymal Stem Cells: Enhance Hematopoiesis after Cord Blood Transplantation | Q46216214 | ||
| Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy | Q46262893 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | imatinib | Q177094 |
| dasatinib | Q419940 | ||
| Philadelphia chromosome | Q1129111 | ||
| lymphoblastic leukemia | Q18553852 | ||
| dasatinib monohydrate | Q27139135 | ||
| P304 | page(s) | 303-306 | |
| P577 | publication date | 2015-08-01 | |
| P1433 | published in | Current Oncology | Q3498968 |
| P1476 | title | Dasatinib for a child with Philadelphia chromosome-positive acute lymphoblastic leukemia and persistently elevated minimal residual disease during imatinib therapy | |
| P478 | volume | 22 |
Search more.